Severity
Low
FDA Drug recall · Reported February 13, 2013
Defective Container: Pump head detaching from the canister unit upon removal of the overcap.
Ascend Therapeutics Inc recalled EstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression, … - a low-severity action.
EstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression, … was recalled by Ascend Therapeutics Inc in February 13, 2013. Reason: Defective Container: Pump head detaching from the canister unit upon removal of the overcap.. Check the official notice for the remedy. Verify recall #D-146-2013 with the FDA Drug before acting.
The recall
Ascend Therapeutics Inc issued this low-severity FDA Drug recall-Defective Container: Pump head detaching from the canister unit upon removal of the overcap..
Sourced from official FDA Drug enforcement records. Verify recall #D-146-2013 with the agency before acting. Full product description, hazard, remedy, and related recalls are below.
This FDA Drug action (record #D-146-2013) was formally reported on February 13, 2013, with the manufacturer initiating the action on November 19, 2012. It is classified under Low severity (Class III), with a current status of Terminated. Ascend Therapeutics Inc is listed as the recalling firm, operating out of Herndon, VA. Federal records list the affected scope as 4, 835 bottles.
The documented reason for this recall is: Defective Container: Pump head detaching from the canister unit upon removal of the overcap. Distribution data in the federal record shows the product reached: Products were distributed nationwide.. Distribution scope directly affects the consumer exposure window and determines whether a recall remains regional or escalates into a nationwide advisory.
Within the same product category the archive holds 6 closely related recalls - clustering in a narrow category often points to a systemic quality-control or supplier issue rather than a one-off defect. Always verify the recall number against the official agency record before acting.
Where this recall sits in its category - 40,322 medical devices recalls on record
Of 101,704 recalls in the database, 24,878 are high severity, 72,426 moderate, and 4,400 low. This recall is classified low severity.
Counts reflect market size and reporting activity, not inherent danger, we do not rank products by risk from raw recall volume.
Severity
Low
Affected scope
4, 835 bottles
Related Recalls
6
0 from same agency
EstroGel (estradiol gel) 0.06%, contained in 50-gr metered pumps, 1.25g/pump depression, for use as physician starter samples; product is labeled in part ***Manufactured for ASCEND Therapeutics Herndon, VA 20170 by DPT Laboratories San Antonio TX 78215***
Defective Container: Pump head detaching from the canister unit upon removal of the overcap.
| Attribute | Value |
|---|---|
| Agency | U.S. Food and Drug Administration |
| Severity class | Low (Class III) |
| Status | Terminated |
| Recall number | D-146-2013 |
| Date reported | February 13, 2013 |
| Date initiated | November 19, 2012 |
| Recalling firm | Ascend Therapeutics Inc |
| Firm location | Herndon, VA |
| Affected scope | 4, 835 bottles |
| Distribution | Products were distributed nationwide. |
Profile values are sourced directly from the official FDA Drug enforcement record. Source: U.S. Food and Drug Administration.
What to do with this recall
Match your product against the recall record, then act on the agency remedy.
This page summarizes the official FDA Drug record for research and awareness; it is not legal, medical, or safety advice. Verify with the issuing agency before acting.
Other recalls in the same product category, useful for spotting patterns across the same defect class or manufacturer.
· 2026-07-02
· 2026-06-25
· 2026-06-18
GE Medical Systems Information Technologies Inc · 2026-06-03
Medline Industries, LP · 2026-06-03
Compare this recall with Rowenta Recalls Cordless Vacuum Cleaners Due to Risk of Ser… →
Every figure on PlainRecalls is rendered directly from official FDA, CPSC and NHTSA recall records, no number is typed in by an editor. This recall: FDA Drug, reported February 13, 2013. Severity classes follow each agency's own taxonomy (FDA Class I/II/III; CPSC and NHTSA by hazard type), and related-recall context is computed across the full archive. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of July 2026.